Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
Primary Purpose
Sexually Transmitted Diseases
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
mHealth Intervention
Sponsored by
About this trial
This is an interventional treatment trial for Sexually Transmitted Diseases
Eligibility Criteria
Inclusion Criteria:
- Adolescent patients seen in the Emergency Department who test positive for gonorrhea, chlamydia, or pelvic inflammatory disease and are prescribed outpatient antibiotic treatment.
Exclusion Criteria:
- Patients will be excluded if they are unable to understand English, are critically ill, have cognitive impairment or if they do not have access to a cellular telephone with text messaging capabilities.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
No Intervention
Arm Label
mHealth
Usual care
Arm Description
Adolescents enrolled in this arm will receive treatment-related text messages.
Adolescents in this arm will receive usual care.
Outcomes
Primary Outcome Measures
STI treatment adherence
Proportion of study participants who complete their medication as prescribed by self-report
Secondary Outcome Measures
STI treatment receipt
Proportion of study participants who receive STI treatment; measured by prescription filling and/or receiving treatment at a healthcare facility
Full Information
NCT ID
NCT04372485
First Posted
April 30, 2020
Last Updated
August 28, 2023
Sponsor
Children's National Research Institute
1. Study Identification
Unique Protocol Identification Number
NCT04372485
Brief Title
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
Official Title
Leveraging Health Information Technology to Reduce Health Disparities in Adolescent Health Outcomes: A Patient-Centered Approach
Study Type
Interventional
2. Study Status
Record Verification Date
August 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
January 2024 (Anticipated)
Primary Completion Date
June 2027 (Anticipated)
Study Completion Date
June 2027 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Children's National Research Institute
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
We will conduct a randomized trial to compare differences in sexually transmitted infection (STI) treatment adherence between patients receiving text messages versus those receiving usual care (e.g. no text messages). We hypothesize that STI treatment adherence will be 20% higher among patients randomized to receipt of two-way text messaging services.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sexually Transmitted Diseases
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
270 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
mHealth
Arm Type
Other
Arm Description
Adolescents enrolled in this arm will receive treatment-related text messages.
Arm Title
Usual care
Arm Type
No Intervention
Arm Description
Adolescents in this arm will receive usual care.
Intervention Type
Behavioral
Intervention Name(s)
mHealth Intervention
Intervention Description
Adolescents will receive text messages to facilitate treatment adherence
Primary Outcome Measure Information:
Title
STI treatment adherence
Description
Proportion of study participants who complete their medication as prescribed by self-report
Time Frame
1-21 days after prescription filling
Secondary Outcome Measure Information:
Title
STI treatment receipt
Description
Proportion of study participants who receive STI treatment; measured by prescription filling and/or receiving treatment at a healthcare facility
Time Frame
1-21 days after STI diagnosis
10. Eligibility
Sex
All
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adolescent patients seen in the Emergency Department who test positive for gonorrhea, chlamydia, or pelvic inflammatory disease and are prescribed outpatient antibiotic treatment.
Exclusion Criteria:
Patients will be excluded if they are unable to understand English, are critically ill, have cognitive impairment or if they do not have access to a cellular telephone with text messaging capabilities.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Meleah Boyle, MPH
Phone
202-476-5388
Email
mdboyle@childrensnational.org
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
We'll reach out to this number within 24 hrs